To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)

Post Marketing Surveillance of Remicade

NCT00724529 ·Status: COMPLETED

Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's Disease

NCT01510431 ·Status: NO_LONGER_AVAILABLE

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

NCT00269854 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

NCT06051253 ·Status: RECRUITING ·Phase: PHASE4

A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

NCT00207766 ·Status: COMPLETED ·Phase: PHASE3

Remission in Subjects With Crohn's Disease, 1 Year Phase

NCT00055497 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)

NCT02849951 ·Status: TERMINATED ·Phase: PHASE3

Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)

NCT00818272 ·Status: COMPLETED

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

NCT00207662 ·Status: COMPLETED ·Phase: PHASE3

Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group

NCT03458195 ·Status: RECRUITING ·Phase: NA

Remicade® Crohn's Disease Registry Across Canada (Study P02793)

NCT00755937 ·Status: TERMINATED

Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)

NCT00705614 ·Status: COMPLETED

Comparison of Endoscopy and Diffusion-weighted Enterography-MRI for the Diagnosis of Crohn's Disease Recurrence Following Ileocolic Resection: a Pilot Study

NCT02867540 ·Status: UNKNOWN ·Phase: NA

Remission in Subjects With Crohn's Disease, Open Label Extension

NCT01070303 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease

NCT00269841 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

NCT03105102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

NCT01190839 ·Status: TERMINATED ·Phase: PHASE3

Stop Infliximab in Patients With Crohn's Disease

NCT00571337 ·Status: COMPLETED ·Phase: PHASE3

Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease

NCT01438151 ·Status: TERMINATED ·Phase: NA

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00055523 ·Status: COMPLETED ·Phase: PHASE2

Improving the Quality of Care for Adults With Inflammatory Bowel Disease

NCT02791854 ·Status: ENROLLING_BY_INVITATION

CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease

NCT01183403 ·Status: COMPLETED

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis

NCT00096655 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease

NCT00055536 ·Status: COMPLETED ·Phase: PHASE2

Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis

NCT02330653 ·Status: COMPLETED ·Phase: PHASE1/PHASE2